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ABSTRACT
Objective To assess the impairment in daily living
activities in older people with age related changes in
white matter according to the severity of these changes.
Design Observational data collection and follow-up of a
cohort of older people undergoing brain magnetic
resonance imaging after non-disabling complaints.
Setting 11 European centres.
Participants 639 non-disabled older patients (mean age
74.1 (SD 5.0), 45.1% men) in whom brain magnetic
resonance imaging showedmild, moderate, or severe age
related changes in whitematter (Fazekas scale). Magnetic
resonance imaging assessment also included cerebral
infarcts and atrophy.
Main outcome measure Transition from no disability
(defined as a score of 0 or 1 on the instrumental activities
of daily living scale) to disability (score ≥2) or death over
three year follow-up. Secondary outcomes were incident
dementia and stroke.
Results Over a mean follow-up period of 2.42 years (SD
0.97, median 2.94 years), information on the main
outcome was available for 633 patients. The annual rate
of transition or death was 10.5%, 15.1%, and 29.5%,
respectively, for patients with mild, moderate, or severe
age related changes in white matter (Kaplan-Meier log
rank test P<0.001). In a Cox model comparing severe with
mild changes and adjusted for clinical factors of
functional decline, the risk of transition to disability or
death was more than twofold higher (hazard ratio 2.36,
95% confidence interval 1.65 to 3.81). The other
predictorswere age group, history of atrial fibrillation, and
complaint of gait disturbances. The effect of severe
changes remained significant independently of baseline
degree of atrophy and number of infarcts. Incident stroke
and dementia only slightly modified this effect.
Conclusion The three year results of the LADIS study
suggest that in older adults who seek medical attention
for non-disabling complaints, severe age related changes
in white matter independently and strongly predict rapid
global functional decline.
INTRODUCTION
Many older people have age related changes in white
matter on brain magnetic resonance imaging. Such
changes, also called leukoaraiosis when detected by
computed tomography1, appear as hyperintense areas
seated in the white matter on T2 weighted magnetic
resonance imaging sequences, from mild focal to
large confluent, in about a third of cases of moderate
to severe grade.2
Cognitive impairment, depression, difficulties in
walking, and urinary incontinence are themain contri-
butors to loss of functional independence in older peo-
ple. All the above have been consistently reported to
be associated with age related changes in white matter
with a potential impact on global functioning.3 There
have been no studies of adequate power primarily
aimed at assessing such changes and their severity in
relation to daily livingdisability. Scarce evidence exists
from one study that examined a small sample of
patients with computed tomography defined leukoar-
aiosis compared with controls without leukoaraiosis4
and from two studies in subsets of patients with selec-
tive clinical presentations (older patients with major
depression,5 patients with subcortical vascular
dementia6).
The LADIS (leukoaraiosis and disability) study is a
multicentre European collaboration that started in
2000 to investigate, through a longitudinal design,
whether age related changes in white matter are an
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independent determinant of functional decline in older
people. Age related pathological processes involved in
the transition from independent functional status to
more substantial disability have not been completely
elucidated. Modern laboratory techniques (for exam-
ple, brain imaging) might help to identify these pro-
cesses. Both prevalence and severity of age related
changes in white matter increase with age, and several
dysfunctions occurring with age and contributing to
disability have been reported to be associated with
such changes, raising the hypothesis that they might
be one of the processes causing disability in older peo-
ple.We need to establish their net contribution in rela-
tion to other factors of disability.We do not knowwhat
grade of changes produces functional effects and
whether there is a dose-effect or a threshold relation
between the severity of changes and the risk of func-
tional decline.
We present the three year follow-up results of the
main prespecified outcome—that is, the transition (in
relation to the baseline grade of age related changes in
white matter) from independence in the instrumental
activities of daily living to disability or death, as evi-
denced in a cohort of older people undergoing brain
magnetic resonance imaging after non-disabling com-
plaints.
METHODS
Full details of the LADIS study are reported
elsewhere.7
End point definition
Our primary end point was transition to disability,
based on Lawton and Brody’s instrumental activity of
daily living scale8 as the change from a score of 0 or 1 at
baseline to a score of 2 ormore or death.Our definition
of transition corresponds with the progression from no
ormild tomoderate or severe disability and is the cate-
gorisation used by longitudinal population based stu-
dies of disability conducted in similar aged cohorts.9-11
We used the risks of such transition plus death (as esti-
mated by these studies) to calculate power and sample
size.7 Twopopulation based studies reported the risk of
the transition from no or mild to moderate or severe
disability to be 25%after three year follow-up in people
aged 65-84.11 12 Assuming that the groupwith themild-
est degree of age related changes in white matter has a
25% risk of transition to disability or death over three
years (equal to that of the general older population), we
needed 800 people to show a significant trend (1.7 esti-
mated relative risk) in the effect of exposure to the three
increasing degrees of severity, with adjustment for age,
reasons for presentation, and comorbidity (α error
probability 5% (two tailed), power 80%). As recruit-
ment proved to be slower than expected, we revised
the original estimation—that is, while it was approach-
ing 600 patients. From a preliminary baseline data ana-
lysis, the participants with severe age related changes
in white matter, although comparable on instrumental
activities of daily living and on most risk factors with
the patients in the other two groups, turned out to have
considerably greater motor and cognitive impairment
than expected, even after adjustment for several other
predictors of disability. We therefore hypothesised
that those in the group with severe changes were
more prone to progress to disability than expected,
and the relative risk among the group with severe
changes compared with the milder changes could be
greater than expected (relative risk 1.7).With a relative
risk of around 2.0, we recalculated that we needed 500
patients to show a significant effect of the increasing
severity of age related changes in white matter on the
risk of transition. Taking into account a probable drop-
out rate of around 20%, we considered it sufficient to
include 650 participants. The final sample, after check-
ing for completeness of data, was 639.
Secondary outcomes in the LADIS study were inci-
dent dementia and stroke, according to the Diagnostic
and Statistical Manual of Mental Disorders, fourth
edition13 and World Health Organization criteria,
respectively.14
Patients
Participants were patients aged 65-84 in whom age
related changes in white matter of any degree were
found when they were being investigated at one of
the 11 collaborating European centres for complaints
such as mild memory or motor problems, minor
cerebrovascular events (non-disabling strokes or tran-
sient ischaemic attacks), mood alterations, and other
minor neurological problems, none interfering with
common activities of daily living. Those with inciden-
tally discovered age related changes in white matter
were also considered. Reasons for referral were
grouped into cognitive, motor or mood complaints;
non-disabling strokes or transient ischaemic attacks;
other neurological symptoms; incidental findings on
computed tomography or magnetic resonance ima-
ging; and participants in a population survey. Table 1
shows numbers of individuals in each category and
their subdivision according to grade of changes. To
be included, patients had to perform without help in
every activity of the instrumental activities of daily liv-
ing scale or had to be limited in only one activity.Other
inclusion criteria were signed informed consent and
the availability of a regularly contactable informant.
The informant was a next of kin or a close friend of
the patient supposedly contactable during follow-up.
Table 1 | Reasons for referral of people enrolled in LADIS study and distribution according to
severity of age related changes in white matter. Figures are numbers (percentages) of
participants
Mild
(n=282)
Moderate
(n=196)
Severe
(n=155)
Total
(n=633)
Mild memory or motor problems,
mood alterations
88 (42.3) 71 (34.1) 49 (23.6) 208 (100)
Minor cerebrovascular events 31 (25.6) 42 (34.7) 48 (39.7) 121 (100)
Incidental computed tomography or MRI finding 56 (52.8) 28 (26.4) 22 (20.8) 106 (100)
Other neurological symptoms 55 (43.3) 43 (33.9) 29 (22.8) 127 (100)
Other study controls, volunteers 52 (73.2) 12 (16.9) 7 (9.9) 71 (100)
MRI=magnetic resonance imaging.
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Reasons for exclusion were lack of age related changes
in white matter, severe illnesses (cardiac, hepatic, or
renal failure, cancer or other relevant systemic dis-
eases), unrelated neurological diseases, leukoencepha-
lopathy of non-vascular origin (immunological-
demyelinating, metabolic, toxic, infectious, other),
and severe psychiatric disorders.
Out of the 897 consecutive patients screened for
inclusion, 180 (20%) were excluded because wrong
age (n=76), disability or presence of severe illnesses
possibly interfering with follow-up assessment (n=57),
absence of age related white matter changes (n=27),
and inability or refusal to undergomagnetic resonance
imaging scanning (n=20), thus leaving 717 eligible
patients. Seventy eight of the eligible patients refused
to participate, and 639 (71% of the screened sample)
were finally enrolled in the study.
Assessment
Entry assessment included a detailed magnetic reso-
nance imaging study and several functional and clini-
cal measures.7 Patients were then asked to undergo
yearly clinical and functional assessments for a maxi-
mum of three years. At entry and at each follow-up
visit, a structured questionnaire was used to assess,
among other variables, education (expressed as years
of schooling), living conditions (alone or with others),
history of myocardial infarction and angina pectoris
(ischaemic heart disease), stroke, heart failure, arrhyth-
mias, arterial hypertension, peripheral vascular
disease, diabetesmellitus, chronic obstructive pulmon-
ary disease, depression, gait disturbances, osteoarthri-
tis, falls in the past year, visual impairment, and
hearing loss. The definition of each variable was
based on recent criteria.7 All the patients underwent a
standard physical examination during which body
mass index and pulse pressure were also recorded.
The instrumental activities of daily living scale
includes eight items: ability to use the telephone,
shopping, food preparation, housekeeping, laundry,
mode of transportation, responsibilities for own medi-
cations, and ability to handle finances.8 Depending on
the type of task, questions were asked as to whether the
taskwas accomplishedwithout any limitation, with dif-
ficulties, or with help. Our outcome variable was no
limitation versus limitation of any degree (either diffi-
culty or need for help) in one or more of the tasks
included in the scale. The IADL scale was adminis-
tered from baseline only to the informant because of
the expectation of cognitive decline at follow-up. The
reliability of scoring between raters and centres, tested
in advance, showed good agreement on each item rat-
ing (κ ranging from 0.69 to 0.85). Functional status was
also assessed with the informant for patients who had
died (assessment related to functional status before
death) or had refused to undergo a follow-up visit.
The date (month) of status change was registered.
All participants underwentmagnetic resonance ima-
ging following a standard protocol, during which 0.5 T
or 1.5 T scanners were used and series included axial
T2 weighted images (echo time 100-120ms; repetition
time 4000-6000 ms; voxel size 1×1×5-7.5 mm3; 19-24
slices), axial fluid attenuated inversion recovery
images (echo time 100-140 ms; repetition time 6000-
10 000 ms; inversion time 2000-2400 ms; voxel size
1×1×5-7.5 mm3; 19-24 slices), and coronal or sagittal
3D T1 sequence (TE 4-7 ms; TR 10-25 ms; flip angle
15-30°; voxel size 1×1×1-1.5 mm3). All scans were
checked and stored at the image analysis centre of the
VUMedical Centre, Amsterdam, Netherlands.
A central raterwhowas blind to the clinical and func-
tional data used the visual Fazekas scale to rate severity
of age related changes in white matter at baseline on
magnetic resonance imaging.15 Accordingly, patients
were subdivided into three severity groups: grade 1
(mild changes): single lesions <10 mm and/or areas
of “grouped” lesions <20 mm in any diameter; grade
2 (moderate changes): single hyperintense lesions 10-
Fig 1 | Age related changes in white matter: three severity grades according to modified Fazekas scale
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20mm, andhyperintense areas linkedbynomore than
“connecting bridges” >20 mm in any diameter; and
grade 3 (severe changes): both single and confluent
hyperintense areas of ≥20 mm in any diameter)
(fig 1). Volumetric assessment was performed on a
Sparc 5 workstation (SUN, Palo Alto, CA). A single
rater used a semi-automated method to measure the
volume of white matter changes on axial fluid attenua-
tion inversion recovery images, both in supratentorial
and infratentorial regions. Lesions were marked and
borders were set with local thresholding (home devel-
oped software Show_Images, version 3.6.1) on each
slice. No distinction was made between subcortical
and periventricular hyperintensities. 16
The LADIS study also assessed several magnetic
resonance imaging variables. As possible confounders
of outcome in our study, we used lacunar infarcts
defined as hypointense foci of ≥3mmon T1 sequences
that were surrounded by white matter or subcortical
grey matter and not located in areas with a high preva-
lence of widened perivascular spaces (for example,
anterior commissure, vertex), the number of lacunes
being recoded into none, few (1-3), and many (≥4)17;
non-lacunar infarcts dichotomised as none/at least
one; and global atrophy, rated on fluid attenuation
inversion recovery scans, for ventricular and sulcal
widening separately, using a template based rating
scale ranging from 1 (no) to 8 (severe) atrophy. The
inter-rater κ was 0.70 for sulcal atrophy and 0.83 for
ventricular atrophy.18 Measures of lacunar infarcts,
non-lacunar infarcts, and atrophy were not available
for two, three, and 109 patients, respectively.
Statistical analysis
In the 633 patients followed up, we first examined var-
iations of baseline demographics, risk factors, and
comorbidities across the three severity groups, asses-
sing significance by means of χ2 test for trend for cate-
gorical variables and trend test (analysis of variance
with polynomial contrast) for continuous variables.
Results are reported as frequency and percentage or
mean and standard deviation.
We expressed the incidence rate of transition to dis-
ability or death (primary end point) and stroke and
dementia (secondary end points) in each of the three
severity groups (Fazekas rating) as number of events
per 100personyears at risk,with 95%confidence inter-
vals.
The Kaplan-Meier curves examined the probability
of surviving free of disability or death across the
Table 2 | Demographics and functional status according to severity of age related changes in white matter (Fazekas scale)
(633 patients with follow-up assessment). Figures are numbers (percentages) of participants unless stated otherwise
Mild (n=282) Moderate (n=196) Severe (n=155) Total (n=633) P value
Sex (male) 128 (45.4) 76 (38.8) 81 (52.3) 285 (45.0) 0.314
Age (years):
65-69 85 (30.1) 46 (23.5) 27 (17.4) 158 (25.0)
0.001
70-74 93 (33.0) 58 (29.6) 49 (31.6) 200 (31.6)
75-79 70 (24.8) 58 (29.6) 54 (34.8) 182 (28.7)
80-84 34 (12.1) 34 (17.3) 25 (16.1) 93 (14.7)
Living condition (with others) 176 (62.4) 109 (55.6) 104 (67.1) 389 (61.5) 0.541
Mean (SD) age (years) 73.3 (5.0) 74.4 (5.1) 75.0 (4.8) 74.1 (5.0) 0.001
Mean (SD) education (years of schooling)* 9.8 (3.6) 9.6 (3.9) 9.3 (4.0) 9.6 (3.8) 0.129
Score 0 v 1 on instrumental activities
of daily living at baseline
36 (12.8) 41 (20.9) 42 (27.1) 119 (18.8) <0.001
*Data missing for one.
Table 3 | Vascular risk factors and comorbidities according to severity of age related changes in white matter (Fazekas scale)
groups (633 patients with follow-up assessment*). Figures are numbers (percentages) of participants unless stated
otherwise
Mild (n=282) Moderate (n=196) Severe (n=155) Total (n=633) P value
Ischaemic heart disease 57 (20.4) 40 (20.4) 30 (19.5) 127 (20.2) 0.828
Heart failure 7 (2.5) 5 (2.6) 9 (5.8) 21 (3.3) 0.086
Arterial hypertension 179 (63.7) 145 (74.0) 118 (76.6) 442 (70.0) 0.003
Atrial fibrillation 21 (7.5) 13 (6.7) 15 (9.7) 49 (7.8) 0.475
Diabetes 33 (11.7) 29 (14.9) 27 (17.8) 89 (14.1) 0.078
History of stroke 49 (17.4) 61 (31.3) 73 (47.1) 183 (28.6) <0.001
Peripheral vascular disease 19 (6.8) 16 (8.2) 10 (6.6) 45 (7.2) 0.952
Mean (SD) BMI 26.1 (4.2) 26.1 (4.1) 26.4 (4.5) 26.2 (4.2) 0.533
Mean (SD) pulse pressure 64.3 (16.9) 66.8 (16.4) 66.8 (15.6) 65.7 (16.5) 0.134
BMI=body mass index.
*Data missing for ischaemic heart disease (4), heart failure (2), arterial hypertension (2), atrial fibrillation (3), diabetes (4), history of stroke (1),
peripheral vascular disease (5).
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severity groups (separated by either the three Fazekas
ranks or volume fifths). We estimated differences
between groupswith the log rank test.Median survival
time in years was also reported.
With the mild group taken as reference,7 we com-
pared the net predictive effect of Fazekas grades on
the primary end point in the severe and moderate
groups with Cox regression analysis, controlling for
the several potential confounders listed in the assess-
ment section. In addition to demographic factors,
these included the factors resulting as the best predic-
tors of decline in global function among older people
in the meta-analysis of Stuck et al.19 Because patients
were enrolled in different centres, we also adjusted for
this factor. In addition, we entered the baseline score
for instrumental activities of daily living (0 or 1).
Finally, to properly control for the different conditions
that had led patients to be included in the study, we
used a Cox model stratified by the reasons for referral
(table 1). In a furthermodel,we controlled for the effect
of age related changes in white matter on transition,
including magnetic resonance imaging infarcts and
atrophy.
During the follow-up period 242 patients reached
the primary end point and 391 did not and were there-
fore censored (that is, were not counted in estimating
the risk of the outcome). Of these 391 censored
patients, 331 had completed the scheduled follow-up
and were considered as non-informative regarding the
outcome. The 60 remaining patients, who had been
observed for shorter periods, were retained as still
potentially informative. Baseline factors did not differ
significantly between these two groups.
Data were analysed with SPSS version 14.
RESULTS
At follow-up, of the 639 patients (mean age 74.1 (SD
5.0) years, 45.1% men) enrolled, we had information
about vital and instrumental activities of daily living
status for 633 (99.1%) (mean age 74.1 (SD 5.0) years,
45.0% men). Among these patients, according to the
three Fazekas grades on baseline magnetic resonance
imaging scan, 44% had mild, 31% had moderate, and
25% had severe age related changes in whitematter. In
three groups compared by clinical and functional fea-
tures at entry, we found that older age, history of arter-
ial hypertension, stroke, falls in the past year,
complaint of gait disturbances, and visual problems
were all more common among patients with the severe
grade (tables 2, 3, and 4).
Over a mean follow-up period of 2.42 years (SD
0.97, median 2.94 years), 242 (38.2%, mean age 75.4
(SD 4.8), 44.2% men) of the 633 patients reached the
study end point. Table 5 shows the frequency of the
composite primary outcome (transition to disability
or death) and of individual outcomes. Patients with
severe age related changes in white matter had a
worse prognosis; about 60% had become disabled or
had died at the end of the follow-up.
The rate (per 100 person years at risk) of transition
from independence in instrumental activities of daily
living activities to disability or death was 10.5 (95%
confidence interval 8.2 to 12.8), 15.1 (11.6 to 18.6),
and 29.5 (23.5 to 35.5) for patients in the mild, moder-
ate, and severe Fazekas scale group, respectively. Sur-
vival analysis carried out for each of the Fazekas scale
grades or volume fifths (fig 2) showed that the probabil-
ity of surviving free of disability or death decreased
with the increasing severity of changes in white matter
(Kaplan-Meier log rank test P<0.001 for either grad-
ing).Whenwe compared themoderate with the severe
group, and the fourth with the fifth group, median sur-
vival times were 3.27 (3.16 to 3.38) v 2.14 (1.67 to 2.62)
and 3.27 (3.12 to 3.42) v 2.09 (1.72 to 2.47) years,
respectively.
The rate (per 100 person years at risk) of transition
from independence in instrumental activities of daily
living activities to disability or death varied according
to the reason for referral (table 6). Patients with mild
memory or motor problems and mood alteration or
Table 4 | Other disabling comorbidities according to severity of age related changes in white matter (Fazekas scale) (633
patients with follow-up assessment*). Figures are numbers (percentages) of participants
Mild (n=282) Moderate (n=196) Severe (n=155) Total (n=633) P value
Depression 78 (27.7) 58 (29.6) 39 (25.2) 175 (27.6) 0.668
Falls in the last year 63 (22.3) 61 (31.3) 57 (36.8) 181 (28.6) 0.001
Osteoarthritis 82 (29.2) 56 (28.7) 39 (25.3) 177 (28.1) 0.421
Chronic obstructive pulmonary disease 27 (9.6) 18 (9.2) 20 (12.9) 65 (10.3) 0.326
Complaint of gait disturbances 100 (35.8) 74 (38.1) 83 (54.6) 257 (41.1) <0.001
Urinary disturbances 110 (39.0) 68 (34.7) 75 (48.4) 253 (40.0) 0.113
Visual impairment 37 (13.1) 35 (17.9) 39 (25.2) 111 (17.5) 0.002
Hearing loss 124 (44.0) 89 (45.4) 73 (47.1) 286 (45.2) 0.528
*Data missing for falls in past year (1), osteoarthritis (3), chronic obstructive pulmonary disease (1), complaint of gait disturbances (8).
Table 5 | Rate (95% confidence interval) per 100 person years at risk of composite outcome
(transition to disability or death) and of individual outcomes according to severity of age
related changes in white matter
Mild Moderate Severe Total sample
Transition to disability
or death
10.5 (8.2 to 12.8) 15.1 (11.6 to 18.6) 29.5 (23.5 to 35.5) 15.8 (13.8 to 17.8)
Transition to disability 9.1 (6.9 to 11.2) 13.7 (10.4 to 17.0) 27.9 (22.1 to 33.8) 14.4 (12.5 to 16.3)
Death 2.1 (1.1 to 3.1) 1.8 (0.7 to 2.9) 5.4 (1.8 to 5.4) 2.4 (1.7 to 3.1)
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minor cerebrovascular events had theworst prognosis,
whereas those enrolled as other study controls or
volunteers the best prognosis. This basically parallels
the different distribution of severe age related changes
in white matter across reason for referral groups.
When we compared the severe with the mild grades
of changes and adjusted for confounders by Cox ana-
lysis (table 7), the hazard of transition to disability or
death was more than twofold higher for the severe
Fazekas group. Other factors that independently pre-
dicted transition or death were age group, history of
atrial fibrillation, complaint of gait disturbances, and
baseline instrumental activities of daily living score of
1. Education and history of osteoarthritis were protec-
tive factors (table 7).
Patients with moderate age related changes in white
matter alsohad a significantly higher risk of transitionor
death in the unadjusted comparisonwith themild group
(hazard ratio 1.48, 1.08 to 2.05), but the difference was
no longer significant after adjustment (table 7). The
attenuation turned out to depend mostly on the effect
of age.Whenweanalysed fifths of volumeof age related
changes in white matter with adjustment for confoun-
ders, the hazard of transition to disability or death was
almost threefold higher (hazard ratio 2.99, 1.77 to 5.05)
comparing the highest fifth with the lowest.
When we considered as outcome the transition to
disability alone (excluding death), the adjusted hazard
ratios were 1.09 (0.74 to 1.59) for patients with moder-
ate changes and2.50 (1.72 to 3.65) for thosewith severe
changes, in comparison with the mild group.
Evidence of multiple lacunar infarcts and non-lacu-
nar infarcts and severity of atrophy on magnetic reso-
nance imaging at baseline was also significantly
associated with the degree of severity of age related
changes in white matter (table 8). When we added
these variables to the Cox model, together with the
three severity grades and all other confounders, severe
changes remained an independent predictor of transi-
tion to disability or death (hazard ratio 2.36, 1.55 to
3.60).
Severity grades of age related changes in white mat-
ter independently predicted the severity of functional
decline as expressed by the mean number of instru-
mental activities of daily living changed by follow-up
(1.09 (SD 1.99) in the mild, 1.42 (SD 2.0) in the mod-
erate, and 2.53 (SD 2.69) in the severe group; P<0.001
after adjustment for confounders). The activities most
commonly limited among patients with functional
decline were housekeeping, shopping, and mode of
transportation
In the mild, moderate, and severe change groups,
the rate (per 100 person years at risk) of incident stroke
was 1.8 (95% confidence interval 0.8 to 2.8), 3.2 (1.6 to
4.9), and 6.9 (4.0 to 9.8), and the rate of incident
dementia was 3.2 (1.9 to 4.5), 4.7 (2.8 to 6.6), and
12.8 (8.9 to 16.6), respectively. Adding incident stroke
and dementia to the Cox regression model only
slightly attenuated the effect of severe changes on tran-
sition to disability or death (hazard ratio 2.06, 1.40 to
3.04).
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Fig 2 | Kaplan-Meier probability of survival free of transition
from independence in instrumental activities daily living to
disability or death according to baseline severity grades in
age related changes in white matter
Table 6 | Rate (95% confidence interval) per 100 person years at risk of transition to disability or death according to reason
for referral and severity of age related changes in white matter
Reasons for referral Mild Moderate Severe Total
Mild memory or motor problems, mood alterations 15.8 (10.5 to 21.0) 21.6 (14.3 to 28.8) 38.1 (25.3 to 50.9) 22.0 (17.7 to 26.2)
Minor cerebrovascular events 7.2 (1.4 to 12.9) 13.4 (6.6 to 20.2) 32.4 (20.8 to 43.9) 17.7 (12.8 to 22.6)
Incidental computed tomography/MRI finding 7.0 (2.8 to 11.1) 11.3 (3.5 to 19.2 28.2 (12.9 to 43.6) 11.7 (7.6 to 15.7)
Other neurological symptoms 10.2 (5.0 to 15.3) 10.9 (4.7 to 17.0) 19.8 (9.0 to 30.5) 12.4 (8.5 to 16.2)
Other study controls, volunteers 8.4 (3.4 to 13.4) 11.7 (0 to 24.9) 11.6 (0 to 27.7) 9.2 (4.7 to 13.7)
MRI=magnetic resonance imaging.
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DISCUSSION
Principal findings
The final results of the LADIS study show that in an
older person undergoing brain magnetic resonance
imaging after a non-disabling complaint, the presence
of severe age related changes in white matter, mea-
sured either visually or volumetrically, predicts a
more rapid decline in global functioning, independent
of age and several factors known to be associated with
disability in older people. This effect does not seem to
be related to baseline cerebral atrophy or infarcts, both
known to be associated with age related changes in
white matter, nor is it consequent to incident strokes,
despite age related changes in white matter being con-
sidered as a stroke marker.20 Part of the effect is
explained by incident dementia, but the influence of
severe changes on disability does not depend exclu-
sively on their ability to determine dementia. The
role of severe changes as a determinant of rapid
functional decline was already evident after an interim
analysis carried out at the one year follow-up.21 Con-
cerning the hypothesised dose-effect relation between
severity grades and the probability of transition or
death, while the predicted number of instrumental
activities of daily living impaired would support the
hypothesis, the analysis of primary outcome by fifths
of volume of changes, showing the remarkable
increased risk for the highest fifth, corroborates the
hypothesis of a threshold effect.
Strength and limitations of the study
Amain limitation to the generalisability of our results is
related to the hospital based design and the recruit-
ment of patients from several different clinical centres,
both possible sources of bias linked with referral and
selection. Adjustment for reason for referral and for
centre did not alter the strength of the effect of age
related changes in white matter on progression to dis-
ability. Statistical adjustment, however,might not have
been enough to fully overcome the referral problem.
Nearly all patients were enrolled after seeking medical
attention and therefore no inference can be made to
subjects with age related white matter changes who
are free of symptoms. The reasons for referral that led
patients to be included in our study were those com-
monly leading to discovery of age related changes in
whitematter in older people, and thus the LADIS sam-
ple simply reflects the population of patients with such
changes likely to be encountered in clinical practice.
Compared with a population based approach,
strengths of a clinical study in this setting include an
adequate number of patients in each severity group,
the detailed and accurate functional andmagnetic reso-
nance imaging assessments, and the low dropout rate.
As in previous studies, we used the instrumental
activities of daily living scale. The reliability and valid-
ity of such a scale is considered sufficient to warrant its
use in clinical situations.22 Data might be subject to
variability depending on sociodemographic factors.23
Our data on agreement between centres show that
the assessment of instrumental activities of daily living
was consistent across several linguistic and sociocul-
tural settings throughout Europe.
Table 8 | Infarcts and atrophy on magnetic resonance imaging according to severity of age related changes in white matter
(Fazekas scale) (633 patients with follow-up assessment*). Figures are numbers (percentages) of participants unless stated
otherwise
Mild (n=282) Moderate (n=196) Severe (n=155) Total (n=633) P value
Lacunar infarcts:
None 182 (64.8) 95 (48.5) 54 (35.1) 331 (52.5)
<0.001Few 82 (29.2) 70 (35.7) 63 (40.9) 215 (34.0)
Many 17 (6.0) 31 (15.8) 37 (24.0) 85 (13.5)
Non-lacunar infarcts:
None 264 (94.3) 179 (91.3) 130 (84.4) 573 (91.0)
0.001
At least one 16 (5.7) 17 (8.7) 24 (15.6) 57 (9.0)
Mean (SD) global atrophy rating 7.5 (2.4) 8.0 (2.4) 8.8 (2.2) 8.0 (2.4) <0.001
*Data missing for lacunar infarcts (2) and non-lacunar infarcts (3).
Table 7 | Effect of severity of age related changes in white matter and other independent
predictors of transition from independence in instrumental activities daily living to disability
or death*
Hazard ratio (95% confidence interval)
Unadjusted Adjusted†
Fazekas grade:
Mild 1 1
Moderate 1.48 (1.08 to 2.05) 1.13 (0.79 to 1.61)
Severe 3.01 (2.22 to 4.08) 2.36 (1.65 to 3.81)
Age group (years):
65-69 1 1
70-74 1.77 (1.20 to 2.62) 1.73 (1.14 to 2.64)
75-79 2.19 (1.49 to 3.22) 1.91 (1.23 to 2.97)
80-84 2.61 (1.71 to 3.99) 2.24 (1.35 to 3.70)
Baseline instrumental activities of daily living=1 3.69 (2.83 to 4.81) 3.08 (2.24 to 4.23)
Atrial fibrillation 2.04 (1.38 to 3.01) 1.69 (1.09 to 2.64)
Complaint of gait disturbances 1.97 (1.52 to 2.54) 1.62 (1.16 to 2.52)
History of osteoarthritis 0.80 (0.60 to 1.08) 0.58 (0.40 to 0.83)
Education (per year of schooling) 0.94 (0.91 to 0.97) 0.90 (0.86 to 0.94)
*Variables in models were age, sex, education, baseline instrumental activities of daily living (0 v 1), centre,
living condition, body mass index, pulse pressure, history of ischaemic heart disease, heart failure,
hypertension, atrial fibrillation, diabetes, depression, falls, osteoarthritis, stroke, chronic obstructive pulmonary
disease, peripheral vascular disease, gait, urinary, visual, or hearing disturbances. Analysis stratified for reason
for referral.
†Cox regression models, adjusted for multiple factors of disability.
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Conclusions and policy implications
Disability in activities of daily living is common among
older people. According to the conceptual model for
the disablement process proposed by Nagi,24 active
organ pathology or disease leads to anatomical and
physiological loss or abnormalities, which in turn
lead to functional limitations resulting in disability.
Organ abnormalities involved in the process of disabil-
ity in older people are still incompletely understood.
Modern imaging techniques have a key role in detect-
ing these abnormalities. Previous studies have consis-
tently shown that age related changes in white matter
predict decline in motor performance,25 onset of
dementia,26 and deterioration in selective cognitive
domains.27 No study has hitherto addressed the ques-
tion of whether such changes are the direct determi-
nant of functional dependence in older people.
Providing an answer to this question might indicate
potential targets for intervention to prevent or slow
down the process.
The fact that age related changes in white matter
affect global functioning in older people indepen-
dently of risk factors and associated comorbidities,
supports the hypothesis that organ damage, as evi-
denced by these changes, directly causes disability.
Anatomical considerations, pathology studies, and epi-
demiological data support this hypothesis.28 Age
related changes in white matter are thought to develop
from repeated ischaemic insults to subcortical brain
areas, mainly caused by small vessel disease.29 From
the histological point of view, these hyperintense
lesions on magnetic resonance imaging correspond to
areas characterised by loss of myelinated fibres and
gliosis without frank tissue necrosis,30 consistent with
the concept of incomplete infarction.28 The currently
accepted view is that these age related changes are a
marker of small vessel disease associated with arterial
hypertension and other vascular risk factors.
Our observations might provide clinicians with spe-
cific evidence to support the use of neuroimaging as an
additional investigation of functional decline in older
people. Whether the systematic use of magnetic reso-
nance imaging scanning in patients presenting with
initial cognitive, mood, or gait disturbances is cost
effective has yet to be determined. In addition, no
conclusive evidence has been reached as yet about
interventions that could favourably alter the develop-
ment of disability in such patients. Preliminary studies,
however, indicate that treating hypertension might
slow the progression of age related changes in white
matter.31 Our data might support clinical research,
helping to design preventive studies. Based on these
data, therapeutic trials—for example, those experi-
menting on the effects of any antihypertensive agent
—should include global functioning among the main
outcomemeasures. In such studies, the risks of disabil-
ity we have reported for the different severity grades of
age related changes in white matter might help to
define the target population and to estimate sample
sizes.
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